Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The Toledo Symphony Orchestra and Local 15-286 of the American Federation of Musicians recently announced the approval of a ...

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

After a lengthy COVID-19 surge this summer, the Bay Area is about to enter the winter respiratory virus season. Explore our ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

Standing desks may increase the risk of swollen veins and blood clots, a study in the International Journal of Epidemiology ...

CIDRAP reports that federal health officials know of 90 cases of Oropouche virus from five states, mostly from Florida, although none of the cases is known to have been sexually transmitted. Plus: ...

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...